My apology the drop did not happen so no news pend
Post# of 478
For those interested monitoring pharms that could be potential buyer's I refer you
to https://www.biospace.com/news/mergers-and-acquisitions/
I regularly search "hemostasis" in the search box.
If I were to gamble I would say J&J is very interested and Baxter Pharm is a potential buyout or merger. Recent news for Baxter "The company is implementing a new operating model to realign its 10 businesses, region-based commercial geographies, and centralized manufacturing and supply chain operations into four vertically integrated global business segments: Medical Products and Therapies; Healthcare Systems and Technologies; Pharmaceuticals and BioPharma Solutions; and Kidney Care (through completion of the proposed spinoff). The company believes this new model will help fuel greater performance through enhanced strategic clarity, accountability, speed and innovation across the new segments".
https://www.biospace.com/article/releases/bax...tasis+news
Just remember our CEO has acquisition/merger experience with Citi Bank!
$5-$10+